China Calling: Dozens Of Drug Firms Handpicked For Fast Track Reviews

Four dozen innovative new drugs are slated to be reviewed under China's fast-track system, including more than 20 products for rare diseases.

China handshake
China offers fast-track reviews to 48 new drugs from multinationals

In its latest move to get new drugs to the market more quickly, China has released a list of products that will receive fast-track reviews, including PCSK9 cholesterol-lowering agents, non-small cell lung cancer treatments, and immuno-oncology agents.

Out of the total of 48 drugs on the list drugs, several have recently received the green light from China's...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from China

More from Asia